CLDX
Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Celldex Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 55.8M, a 23.12% increase year-over-year.
- Celldex Therapeutics Inc. total liabilities for 2025 were 55.8M, a 23.12% increase from 2024.
- Celldex Therapeutics Inc. total liabilities for 2024 were 45.3M, a 24.36% increase from 2023.
- Celldex Therapeutics Inc. total liabilities for 2023 were 36.5M, a 37.41% increase from 2022.
- Celldex Therapeutics Inc. total liabilities for 2022 were 26.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Celldex Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $56 |
| 2024 | $45 |
| 2023 | $36 |
| 2022 | $27 |
| 2021 | $25 |
| 2020 | $26 |
| 2019 | $29 |
| 2018 | $32 |
| 2017 | $79 |
| 2016 | $118 |
| 2015 | $47 |
| 2014 | $36 |
| 2013 | $27 |
| 2012 | $30 |
| 2011 | $29 |
| Celldex Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $56 |
| 2024-12-31 | $45 |
| 2023-12-31 | $36 |
| 2022-12-31 | $27 |
| 2021-12-31 | $25 |
| 2020-12-31 | $26 |
| 2019-12-31 | $29 |
| 2018-12-31 | $32 |
| 2017-12-31 | $79 |
| 2016-12-31 | $118 |
| 2015-12-31 | $47 |
| 2014-12-31 | $36 |
| 2013-12-31 | $27 |
| 2012-12-31 | $30 |
| 2011-12-31 | $29 |
| 2010-12-31 | $35 |
Celldex Therapeutics Inc. Total Liabilities — FAQ
Celldex Therapeutics Inc. (CLDX) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLDX's total liabilities history?
The chart and table above show Celldex Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.